pentasa 1 g tablete s produljenim oslobađanjem
ferring gmbh, wittland 11, kiel, njemačka - mesalazin - tableta s produljenim oslobađanjem - urbroj: 1 tableta sadrži 1 g mesalazina
pentasa 2 g granule s produljenim oslobađanjem u vrećici
ferring gmbh, wittland 11, kiel, njemačka - mesalazin - granule s produljenim oslobađanjem u vrećici - urbroj: jedna vrećica sadrži 2 g mesalazina
gabagamma 300 300mg kapsula, tvrda
"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - gabapentin - kapsula, tvrda - 300mg
gabagamma 300 300mg kapsula, tvrda
"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - gabapentin - kapsula, tvrda - 300mg
clopidogrel dura
mylan dura gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotska sredstva - Клопидогрел prikazan odrasle za prevenciju атеротромботических događaja:pacijenti koji pate инфарктом miokarda (od nekoliko dana do manje od 35 dana), ishemijski moždani udar (od 7 dana prije manje od 6 mjeseci) ili instaliranim bolest perifernih arterija.
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastična sredstva - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
gabagamma 400 400mg kapsula, tvrda
"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - gabapentin - kapsula, tvrda - 400mg
gabagamma 400 400mg kapsula, tvrda
"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - gabapentin - kapsula, tvrda - 400mg
moxogamma 0.2 0.2mg film tableta
"worwag pharma gmbh &co.kg", boblingen, njemaČka-dio stranog druŠtva podgorica - moksonidin - film tableta - 0.2mg